InventisBio Co News
News
0
Ticker
688382.SS
ISIN
CNE100005Q22
InventisBio Co Eulerpool News
InventisBio Co Stock News
InventisBio Co is being monitored by journalists and investors worldwide. We gather the latest InventisBio Co news here.
InventisBio Co Stock Press Releases
InventisBio Co regularly publishes news on the company's website that are relevant for investors.
InventisBio Co News 2026
This page contains all current news, analysis and press releases for InventisBio Co stock (688382.SS, ISIN: CNE100005Q22). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at InventisBio Co.
InventisBio Co Stock
InventisBio Co InventisBio Co Ltd, headquartered in Shanghai, China, operates in the Health Care sector within the Biotechnology industry. The company employs 222 full-time staff and completed its IPO on July 25, 2022. InventisBio focuses on drug research and development for major diseases including tumors and metabolic conditions. Its core products under clinical development include D-0120, D-0502, D-1553, and BPI-D0316, targeting oncology and metabolic disease areas.